Qualis Innovations, Inc.
Qualis Innovations, Inc. (QLIS) Stock Overview
Explore Qualis Innovations, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.5M
P/E Ratio
-32.11
EPS (TTM)
$0.12
ROE
-1.41%
QLIS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Qualis Innovations, Inc. (QLIS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.30.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -32.11 and a market capitalization of 5.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Qualis Innovations, Inc. focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. The company is headquartered in Chadds Ford, Pennsylvania.
Patrick S. Adams CFA
225 Wilmington West Chester Pike, Chadds Ford, PA
2007